Sirtuin 3 Mediates Neuroprotection of Ketones against Ischemic Stroke

Stroke is one of the leading causes of death. Growing evidence indicates that ketone bodies have beneficial effects in treating stroke, but their underlying mechanism remains unclear. Our previous study showed ketone bodies reduced reactive oxygen species by using NADH as an electron donor, thus increasing the NAD+/NADH ratio. In this study, we investigated whether mitochondrial NAD+-dependent Sirtuin 3 (SIRT3) could mediate the neuroprotective effects of ketone bodies after ischemic stroke. We injected mice with either normal saline or ketones (beta-hydroxybutyrate and acetoacetate) at 30 minutes after ischemia induced by transient middle cerebral artery (MCA) occlusion. We found that ketone treatment enhanced mitochondria function, reduced oxidative stress, and therefore reduced infarct volume. This led to improved neurologic function after ischemia, including the neurologic score and the performance in Rotarod and open field tests. We further showed that ketones' effects were achieved by upregulating NAD+-dependent SIRT3 and its downstream substrates forkhead box O3a (FoxO3a) and superoxide dismutase 2 (SOD2) in the penumbra region since knocking down SIRT3 in vitro diminished ketones' beneficial effects. These results provide us a foundation to develop novel therapeutics targeting this SIRT3-FoxO3a-SOD2 pathway.

[1]  C. Gibson,et al.  Stroke outcome in the ketogenic state – a systematic review of the animal data , 2012, Journal of neurochemistry.

[2]  Eric Verdin,et al.  Mammalian Sir2 Homolog SIRT3 Regulates Global Mitochondrial Lysine Acetylation , 2007, Molecular and Cellular Biology.

[3]  K. Jellinger,et al.  Buspirone and dystonia , 1991, Neurology.

[4]  T. Eckle,et al.  Ischemia and reperfusion—from mechanism to translation , 2011, Nature Medicine.

[5]  F. Schweizer,et al.  Ubiquitination Acutely Regulates Presynaptic Neurotransmitter Release in Mammalian Neurons , 2010, The Journal of Neuroscience.

[6]  P. Sawchenko,et al.  Loss of Modifier of Cell Adhesion Reveals a Pathway Leading to Axonal Degeneration , 2009, The Journal of Neuroscience.

[7]  S. Park,et al.  Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. , 2010, Molecular cell.

[8]  S. Coons,et al.  Association of amyloid burden, brain atrophy and memory deficits in aged apolipoprotein ε4 mice. , 2014, Current Alzheimer research.

[9]  Danica Chen,et al.  Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. , 2010, Cell metabolism.

[10]  Rui Liu,et al.  Pinocembrin protects brain against ischemia/reperfusion injury by attenuating endoplasmic reticulum stress induced apoptosis , 2013, Neuroscience Letters.

[11]  R. Efremov,et al.  Respiratory complex I: 'steam engine' of the cell? , 2011, Current opinion in structural biology.

[12]  J. Rho,et al.  Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation , 2007, Neuroscience.

[13]  S. Biswas,et al.  FoxO3a is activated and executes neuron death via Bim in response to β-amyloid , 2013, Cell Death and Disease.

[14]  Mark Ellisman,et al.  Autophagy and Apoptosis Are Differentially Induced in Neurons and Astrocytes Treated with an In Vitro Mimic of the Ischemic Penumbra , 2012, PloS one.

[15]  G. Bachmann,et al.  Noninvasive Quantification of Brain Edema and the Space-Occupying Effect in Rat Stroke Models Using Magnetic Resonance Imaging , 2004, Stroke.

[16]  V. Feigin,et al.  Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010 , 2014, The Lancet.

[17]  F. Shi,et al.  Ischemic neurons recruit natural killer cells that accelerate brain infarction , 2014, Proceedings of the National Academy of Sciences.

[18]  Michael A. Rogawski,et al.  Neuroprotective and disease-modifying effects of the ketogenic diet , 2006, Behavioural Pharmacology.

[19]  E. Reiman,et al.  Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity , 2014, Neurobiology of Aging.

[20]  R. Korthuis,et al.  Mitochondrial reactive oxygen species: A double edged sword in ischemia/reperfusion vs preconditioning , 2014, Redox biology.

[21]  C. Calautti,et al.  Progress in imaging stroke: emerging clinical applications. , 2003, British medical bulletin.

[22]  Jong M. Rho,et al.  The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies , 2009, Brain Research Reviews.

[23]  Teng-Nan Lin,et al.  Effect of Brain Edema on Infarct Volume in a Focal Cerebral Ischemia Model in Rats , 1993, Stroke.

[24]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[25]  D. Reutens,et al.  Apoptotic mechanisms after cerebral ischemia. , 2009, Stroke.

[26]  V. Borutaite,et al.  In the eye of the storm: mitochondrial damage during heart and brain ischaemia , 2013, The FEBS journal.

[27]  M. Prins,et al.  Cerebral Metabolic Adaptation and Ketone Metabolism after Brain Injury , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  V. Darley-Usmar,et al.  Reoxygenation-dependent decrease in mitochondrial NADH:CoQ reductase (Complex I) activity in the hypoxic/reoxygenated rat heart. , 1991, The Biochemical journal.

[29]  I. Loubinoux,et al.  Spreading of vasogenic edema and cytotoxic edema assessed by quantitative diffusion and T2 magnetic resonance imaging. , 1997, Stroke.

[30]  Lothar A. Blatter,et al.  Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease , 2014, Front. Physiol..

[31]  O. Hurtado,et al.  Silent Information Regulator 1 Protects the Brain Against Cerebral Ischemic Damage , 2013, Stroke.

[32]  C. Simone,et al.  A novel AMPK-dependent FoxO3A-SIRT3 intramitochondrial complex sensing glucose levels , 2013, Cellular and Molecular Life Sciences.

[33]  Gene Kim,et al.  Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. , 2009, The Journal of clinical investigation.

[34]  H. Schmidt,et al.  Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress. , 2013, Antioxidants & redox signaling.

[35]  T. Finkel,et al.  Mitochondrial metabolism, sirtuins, and aging. , 2012, Cold Spring Harbor perspectives in biology.

[36]  S. Coons,et al.  Deficits in spatial learning and memory is associated with hippocampal volume loss in aged apolipoprotein E4 mice. , 2011, Journal of Alzheimer's disease : JAD.

[37]  M. Endres,et al.  Characterization of long-term functional outcome in a murine model of mild brain ischemia , 2013, Journal of Neuroscience Methods.

[38]  Michèle Allard,et al.  Brain fuel metabolism, aging, and Alzheimer's disease. , 2011, Nutrition (Burbank, Los Angeles County, Calif.).